Ramsay Health Care Stock Current Valuation
| RHC Stock | 39.40 0.16 0.40% |
Valuation analysis of Ramsay Health Care helps investors to measure Ramsay Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Ramsay Health's Cash is comparatively stable compared to the past year. Cash And Short Term Investments is likely to gain to about 695.4 M in 2024, despite the fact that Other Cashflows From Financing Activities is likely to grow to (443.1 M). Fundamental drivers impacting Ramsay Health's valuation include:
Price Book 1.8523 | Enterprise Value 19.3 B | Enterprise Value Ebitda 10.7118 | Price Sales 0.5471 | Forward PE 28.6533 |
Fairly Valued
Today
Please note that Ramsay Health's price fluctuation is very steady at this time. Calculation of the real value of Ramsay Health Care is based on 3 months time horizon. Increasing Ramsay Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Ramsay Health's intrinsic value may or may not be the same as its current market price of 39.40, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 39.4 | Real 39.88 | Hype 39.4 |
The intrinsic value of Ramsay Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ramsay Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ramsay Health Care helps investors to forecast how Ramsay stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ramsay Health more accurately as focusing exclusively on Ramsay Health's fundamentals will not take into account other important factors: Ramsay Health Care Company Current Valuation Analysis
Ramsay Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Ramsay Health Current Valuation | 19.35 B |
Most of Ramsay Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ramsay Health Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Ramsay Health Care has a Current Valuation of 19.35 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all Australia stocks is notably lower than that of the firm.
Ramsay Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ramsay Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ramsay Health could also be used in its relative valuation, which is a method of valuing Ramsay Health by comparing valuation metrics of similar companies.Ramsay Health is currently under evaluation in current valuation category among its peers.
Ramsay Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Ramsay Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Ramsay Health's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Ramsay Fundamentals
| Return On Equity | 0.0509 | ||||
| Return On Asset | 0.028 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 19.35 B | ||||
| Shares Outstanding | 230.25 M | ||||
| Shares Owned By Insiders | 20.39 % | ||||
| Shares Owned By Institutions | 40.63 % | ||||
| Price To Book | 1.85 X | ||||
| Price To Sales | 0.55 X | ||||
| Revenue | 16.67 B | ||||
| Gross Profit | 1.65 B | ||||
| EBITDA | 1.81 B | ||||
| Net Income | 270.6 M | ||||
| Cash And Equivalents | 314.2 M | ||||
| Total Debt | 10.94 B | ||||
| Book Value Per Share | 20.31 X | ||||
| Cash Flow From Operations | 1.3 B | ||||
| Earnings Per Share | 1.15 X | ||||
| Price To Earnings To Growth | 1.66 X | ||||
| Target Price | 45.31 | ||||
| Number Of Employees | 90 K | ||||
| Beta | 0.63 | ||||
| Market Capitalization | 9.12 B | ||||
| Total Asset | 21.34 B | ||||
| Retained Earnings | 2.5 B | ||||
| Working Capital | (307.5 M) | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 21.34 B | ||||
| Last Dividend Paid | 0.8 |
About Ramsay Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ramsay Health Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ramsay Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ramsay Health Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ramsay Stock Analysis
When running Ramsay Health's price analysis, check to measure Ramsay Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ramsay Health is operating at the current time. Most of Ramsay Health's value examination focuses on studying past and present price action to predict the probability of Ramsay Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ramsay Health's price. Additionally, you may evaluate how the addition of Ramsay Health to your portfolios can decrease your overall portfolio volatility.